The Glow Stack: GHK-Cu, BPC-157, and TB-500 for Skin and Hair Research

GHK-Cu: the skin remodeling signal

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. Its plasma concentration declines significantly with age — from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60 — a decline that parallels the deterioration in skin elasticity, wound healing speed, and hair follicle function observed across the same period. The correlation is mechanistically grounded: GHK-Cu has been shown to activate gene expression programs associated with tissue repair and regeneration that are progressively silenced with age.

Specifically, GHK-Cu activates approximately 31% of human genes associated with tissue remodeling and repair, including upregulation of collagen and elastin synthesis, modulation of TGF-β to reduce fibrosis and scar formation, inhibition of inflammatory cytokines, stimulation of antioxidant enzyme activity, and promotion of hair follicle size and cycling. A landmark analysis using gene expression profiling found that GHK-Cu application to aged skin tissue partially reversed the gene expression pattern toward a younger, more active repair state — one of the few compounds to demonstrate this type of broad epigenetic reset in skin tissue.

In skin research: GHK-Cu has demonstrated acceleration of wound healing and reduction of fine lines and wrinkles through collagen restoration, improvement in skin laxity and firmness, and protective effects against UV-induced skin damage. In hair research: GHK-Cu promotes hair follicle size, stimulates hair fiber production, and has shown potential in androgenic alopecia research. Research protocol: 1–2mg subcutaneous daily for 30 days, 14-day break between cycles. See the GHK-Cu research profile.

BPC-157: vascularization and growth factor support

BPC-157 contributes to the Glow Stack through its VEGFR2-driven angiogenesis — creating new blood vessel networks that deliver oxygen and nutrients to skin and hair follicle tissue. The growth hormone receptor upregulation in fibroblasts is also relevant for skin: fibroblasts are the primary producers of collagen and elastin, and amplifying their GH receptor expression enhances their response to growth signals in the repair environment. The anti-inflammatory cytokine reduction reduces the chronic low-grade inflammation that drives premature skin aging and hair follicle miniaturization.

TB-500: anti-fibrotic and cellular mobilization

TB-500's anti-fibrotic effects are particularly relevant to the Glow Stack. Fibrosis — the excessive deposition of collagen in a disorganized pattern — is a major driver of scar formation, skin thickening, and the loss of normal tissue architecture that characterizes photoaged skin. TB-500's amino acid 1–4 segment has documented anti-fibrotic activity, while its G-actin sequestration mechanism drives the migration of repair-competent cells (including keratinocytes and fibroblasts) into the skin tissue being remodeled. The Wnt/β-catenin pathway activation confirmed in a 2024 TB-500 study is also directly relevant — this pathway governs skin stem cell proliferation and hair follicle cycling.

The Glow Blend protocol

The Peptide Hub database includes a pre-formulated Glow Blend combining GHK-Cu 27mg, BPC-157 5mg, and TB-500 10mg in a single vial. Research doses typically range from 900mcg–1800mcg administered subcutaneously daily. Reconstitution follows the standard protocol: inject bacteriostatic water slowly down the vial wall, swirl gently, do not shake. Store refrigerated after reconstitution. Individual profiles with interactive dose calculators are available in the database for each component.

Research sourcing: For research-grade GHK-Cu, BPC-157, and TB-500 with third-party COA documentation, Peptide Hub recommends Amino Club (partner code: PEPTIDEHUB). Affiliate link — we earn a commission at no cost to you.